Evolution Wealth Advisors LLC Decreases Holdings in SPDR S&P Biotech ETF $XBI

Evolution Wealth Advisors LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,434 shares of the exchange traded fund’s stock after selling 1,139 shares during the quarter. Evolution Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,114,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. DHJJ Financial Advisors Ltd. purchased a new stake in SPDR S&P Biotech ETF during the second quarter valued at $25,000. Garrison Bradford & Associates Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $39,000. Quaker Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 101.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 53,536 shares during the period. Avalon Trust Co bought a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $57,000. Finally, Curio Wealth LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 74,700.0% in the second quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock worth $62,000 after buying an additional 747 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 1.9%

Shares of NYSEARCA XBI opened at $111.91 on Friday. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $114.96. The firm has a market capitalization of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The firm has a 50 day moving average of $103.81 and a 200 day moving average of $91.25.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.